Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.
Homann J, Korologou-Linden R, Viallon V, Morgan S, Dobricic V, Deecke L, Schessner JP, Smith-Byrne K, Birtles D, Zhao Y, Wuu J, Artaud F, Hajizadah F, Huerta JM, Ohlei O, Lebedev M, Kolijn PM, Guevara M, Jimenez-Zabala A, Sánchez MJ, Trobajo-Sanmartín C, Colorado-Yohar SM, Alonso-Martín S, Petrova D, Sieri S, Berger K, Peters S, Wareham N, Kaaks R, Travis RC, Vermeulen RCH; Global Neurodegeneration Proteomics Consortium (GNPC); Tzoulaki I, Elbaz A, Mann M, Sacerdote C, Masala G, Katzke V, Benatar M, Bertram L, Middleton L, Riboli E, Gunter MJ, Ferrari P, Robinson O, Lill CM.
Homann J, et al.
medRxiv [Preprint]. 2025 Aug 28:2025.08.20.25334061. doi: 10.1101/2025.08.20.25334061.
medRxiv. 2025.
PMID: 40909834
Free PMC article.
Preprint.